Summary & Overview
HCPCS Level II Q4291: Lamellas xt per Square Centimeter, Add-On Graft Material
HCPCS Level II code Q4291 denotes Lamellas xt billed per square centimeter as an add-on supply or graft material reported in addition to a primary procedure. As an add-on HCPCS Level II code, it is used when a specific graft product is applied over a measured area during a surgical or procedural intervention. Nationally, add-on supply codes like Q4291 matter because they affect bundled payment accounting, documentation requirements, and facility billing for specialty procedures that use area-based grafts.
Key payers referenced in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of the code's clinical context, the typical site of service, and payer coverage considerations. The report also summarizes expected billing practices for area-based add-on materials, common modifier usage where applicable, and implications for claims processing and reimbursement recognition. Where input data is incomplete, the text notes that specific payer policy details or associated taxonomies are not available.
This summary provides clinicians, billing professionals, and policy analysts with essential context for coding and reporting Q4291, plus pointers to the types of benchmarks and policy guidance that influence national payment and documentation practices.
Billing Code Overview
HCPCS Level II code Q4291 describes Lamellas xt, per square centimeter (add-on, list separately in addition to primary procedure). This code represents an add-on product or material billed in conjunction with a primary surgical or procedural service and is reported by area (per square centimeter).
Service type: Supply/Implantable Graft Material
Typical site of service: Operating room or procedural suite
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 57-year-old patient with a full-thickness skin defect of the lower leg following excision of a non-healing ulcer is scheduled for reconstructive soft-tissue repair using a laminated dermal matrix product billed as Q4291 (Lamellas xt, per square centimeter). The procedure is performed in an outpatient ambulatory surgery center or hospital operating room under regional or general anesthesia. The surgical workflow typically includes debridement of nonviable tissue, measurement of the defect in square centimeters, placement and fixation of the lamellar dermal matrix to the wound bed, and coverage with a split-thickness skin graft or secondary closure as indicated. Intraoperative documentation records the product name, number of square centimeters applied, indication (e.g., chronic ulcer, traumatic soft-tissue loss), and any adjunctive maneuvers (negative pressure wound therapy, graft fixation). Postoperative care includes wound checks, dressing changes, and staged graft take assessments over 1–4 weeks, with possible modifier reporting for surgical team, bilateral procedures, or discontinuity if complications occur.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier required (placeholder) | Rarely appended; use payer guidance if a specific modifier is not applicable |